Cutaneous T-cell Lymphoma Research Articles

A-224 Evaluating the Impact of Phototherapy on Cardiovascular Risk in Cutaneous T-Cell Lymphoma: A Retrospective Analysis

A-224 Evaluating the Impact of Phototherapy on Cardiovascular Risk in Cutaneous T-Cell Lymphoma: A Retrospective Analysis

Subcutaneous Panniculitis-like T-cell Lymphoma

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a primary, rare cutaneous T-cell lymphoma that resembles panniculitis and accounts for <1% of all peripheral T-cell lymphomas. It is characterized by multiple subcutaneous nodules and plaques, which usually involve the extremities. Histopathological findings include the presence of neoplastic T-cell surround and disrupt individual adipocyte membranes. Immunohistochemistry will confirm diagnosis by CD8+ and CD56− cells. Here, we report a case of a 29-year-old female who presented with cutaneous panniculitis-like lesions diagnosed with cutaneous T-cell lymphoma with the help of histopathology and immunohistochemistry.

A-133 Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma

A-133 Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma

A-143 The role of OX-40 in tumor microenvironment of a Cutaneous T-cell Lymphoma (CTCL) in vivo chick embryo model

A-143 The role of OX-40 in tumor microenvironment of a Cutaneous T-cell Lymphoma (CTCL) in vivo chick embryo model

A-142 Cutaneous T-cell lymphoma in pregnancy: disease activity and outcomes

A-142 Cutaneous T-cell lymphoma in pregnancy: disease activity and outcomes

A-254 Comparing Responses to Romidepsin Monotherapy and the Sequential Treatment of Romidepsin Followed by Mogamulizumab for Advanced Cutaneous T-cell Lymphoma

A-254 Comparing Responses to Romidepsin Monotherapy and the Sequential Treatment of Romidepsin Followed by Mogamulizumab for Advanced Cutaneous T-cell Lymphoma

A-292 Immunologic changes following chlormethine gel treatment in Cutaneous T-cell Lymphoma patients

A-292 Immunologic changes following chlormethine gel treatment in Cutaneous T-cell Lymphoma patients

S3908 Cutaneous T-Cell Lymphoma in Ulcerative Colitis Patient: A Novel Association With Vedolizumab Therapy

S3908 Cutaneous T-Cell Lymphoma in Ulcerative Colitis Patient: A Novel Association With Vedolizumab Therapy

A-107 Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib

A-107 Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib

A-250 Modes of metastasis: scRNAseq profiling of cutaneous T-cell lymphoma highlights CXCL13, TUSC3, and ANK1 in malignant T cells

A-250 Modes of metastasis: scRNAseq profiling of cutaneous T-cell lymphoma highlights CXCL13, TUSC3, and ANK1 in malignant T cells

A-232 Outcome of cutaneous T-cell lymphomas after allogeneic hematopoietic stem cell transplantation : focus on relapses and their management

A-232 Outcome of cutaneous T-cell lymphomas after allogeneic hematopoietic stem cell transplantation : focus on relapses and their management

A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

A-153 Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2

A-153 Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2

P5-2 Efficacy and safety of extracorporeal photopheresis as immunotherapy for cutaneous T-cell lymphoma: a systematic review

P5-2 Efficacy and safety of extracorporeal photopheresis as immunotherapy for cutaneous T-cell lymphoma: a systematic review

A-229 Identification of clones by TCR Vβ repertoire analysis supports diagnosis of leukemic cutaneous T-cell lymphoma

A-229 Identification of clones by TCR Vβ repertoire analysis supports diagnosis of leukemic cutaneous T-cell lymphoma

A-221 The effect of Anthracycline treatment on primary cutaneous T-cell lymphoma cells

A-221 The effect of Anthracycline treatment on primary cutaneous T-cell lymphoma cells

A-264 Enhanced Phototherapeutic Efficacy Through Microbial Modulation in Cutaneous T-Cell Lymphoma delays tumour growth and increases survival in the murine EL4 model

A-264 Enhanced Phototherapeutic Efficacy Through Microbial Modulation in Cutaneous T-Cell Lymphoma delays tumour growth and increases survival in the murine EL4 model

56 (PB044): Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-World Single- Centre Case Series

56 (PB044): Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-World Single- Centre Case Series

A-261 The impact of atopic dermatitis preceding cutaneous T-cell lymphoma and its effect on clinical outcomes: a retrospective review at a single tertiary referral center

A-261 The impact of atopic dermatitis preceding cutaneous T-cell lymphoma and its effect on clinical outcomes: a retrospective review at a single tertiary referral center

Cutaneous T-cell lymphomas

Cutaneous T-cell lymphomas